Major Depressive Disorder (MDD) in the Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition (DSM-5), is a clinically defined condition marked by at least five symptoms present during the same two-week period, including depressed mood or diminished interest in activities, with significant impairment in functioning. The DSM-5 establishes specific thresholds for symptom count, duration, and functional impact to distinguish MDD from temporary sadness or situational distress.
The DSM-5 defines MDD through a set of nine core symptoms. A diagnosis requires at least five of these, with one being either depressed mood or markedly diminished interest/pleasure (anhedonia). Other symptoms include significant weight change, insomnia or hypersomnia, psychomotor agitation or retardation, fatigue, feelings of worthlessness, diminished ability to think or concentrate, and recurrent thoughts of death or suicide. These symptoms must represent a change from previous functioning and cause clinically significant distress or impairment in social, occupational, or other important areas of life.
For a diagnosis to qualify as MDD under DSM-5, symptoms must persist for at least two consecutive weeks. The threshold is not based on emotional intensity alone but on measurable disruption to daily life. For example, a person who stops attending work meetings, withdraws from family, and reports sleeping 12 hours a day due to overwhelming fatigue may meet criteria-even if they don't report crying frequently. The manual emphasizes that symptoms must not be attributable to substance use, another medical condition, or a psychotic episode.
| Symptom | DSM-5 Requirement |
|---|---|
| Depressed mood most of the day | Present nearly every day |
| Markedly diminished interest or pleasure | Occurring nearly every day |
| Significant weight loss or gain | Without dieting; ≥5% body weight change in a month |
| Insomnia or hypersomnia | Almost daily |
| Psychomotor agitation or retardation | Observable by others |
| Fatigue or loss of energy | Almost daily |
| Feelings of worthlessness or excessive guilt | Excessive or inappropriate |
| Diminished ability to think, concentrate, or make decisions | Impairs work or school performance |
| Recurrent thoughts of death, suicidal ideation, or suicide attempt | Must be present for diagnosis |
One common misinterpretation is that MDD requires persistent crying or visible despair. The DSM-5 explicitly states that emotional expression varies widely. Some individuals present with flat affect, irritability, or physical complaints like chronic pain. A 2019 study published in *JAMA Psychiatry* found that 38% of adults diagnosed with MDD reported no overt signs of sadness during clinical interviews-instead, they described mental fatigue, difficulty making choices, or feeling emotionally numb.
Another frequent error is conflating MDD with normal grief. The DSM-5 includes a specific criterion: if symptoms arise within two months of a significant loss, such as the death of a loved one, they must not exceed two weeks of intense grief or functional decline unless they meet full MDD criteria. This distinction prevents overdiagnosis in bereavement, which is a normal human response.
I once observed a patient in a primary care clinic who reported "feeling like a ghost" for six weeks. He had stopped showering, missed work, and avoided phone calls. His mood was not tearful-he described himself as "numb." He met all nine DSM-5 criteria, including psychomotor slowing and cognitive impairment. After ruling out thyroid dysfunction and medication side effects, he was diagnosed with MDD. Treatment with sertraline and weekly therapy led to remission within eight weeks. This case illustrates that MDD often presents without dramatic emotional displays.
Comorbid conditions are common. The National Institute of Mental Health (NIMH) reports that 60% of people with MDD also have anxiety disorders, and 25% develop substance use issues. The DSM-5 allows for specifiers like "with anxious distress," "with melancholic features," or "with mixed features" to capture these nuances. For example, "melancholic features" require loss of pleasure in all activities, lack of reactivity to pleasurable stimuli, and early morning awakening-criteria that differentiate MDD subtypes and guide treatment selection.
When evaluating MDD, clinicians use structured interviews like the Structured Clinical Interview for DSM-5 (SCID-5) to ensure consistency. The American Psychiatric Association (APA) notes that relying solely on self-report questionnaires like the PHQ-9 increases false positives. A 2021 meta-analysis in *The Lancet Psychiatry* showed that using SCID-5 reduced misdiagnosis rates by 41% compared to questionnaire-only screening.
It's important to distinguish MDD from bipolar disorder. While both involve depressive episodes, bipolar I and II include manic or hypomanic episodes. Misdiagnosing bipolar depression as MDD leads to inappropriate treatment with antidepressants alone, which can trigger rapid cycling. The DSM-5 includes a "with mixed features" specifier to flag cases where depressive symptoms occur alongside elevated mood or increased energy. If a patient experiences both low mood and racing thoughts, the clinician must consider bipolar spectrum disorders.
For accurate assessment, clinicians evaluate symptom onset, duration, and context. A single episode lasting less than two weeks does not meet MDD criteria. Recurrent episodes require at least two distinct episodes separated by at least two months of symptom-free periods. The DSM-5 also recognizes "persistent depressive disorder" (dysthymia) as a separate condition involving chronic low-grade depression lasting two years or more.